☰

Diane C. Shugars - Publications

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Molecular Biology, Microbiology Biology
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Gray L, Fiscus S, Shugars D. HIV-1 variants from a perinatal transmission pair demonstrate similar genetic and replicative properties in tonsillar tissues and peripheral blood mononuclear cells. Aids Research and Human Retroviruses. 23: 1095-1104. PMID 17919104 DOI: 10.1089/Aid.2006.0247  0.578
2005 Jana NK, Gray LR, Shugars DC. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: A role for SLPI in innate mucosal immunity Journal of Virology. 79: 6432-6440. PMID 15858026 DOI: 10.1128/Jvi.79.10.6432-6440.2005  0.651
2005 Chattopadhyay A, Caplan DJ, Slade GD, Shugars DC, Tien HC, Patton LL. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Community Dentistry and Oral Epidemiology. 33: 35-44. PMID 15642045 DOI: 10.1111/J.1600-0528.2004.00194.X  0.546
2005 Chattopadhyay A, Caplan DJ, Slade GD, Shugars DC, Tien HC, Patton LL. Incidence of oral candidiasis and oral hairy leukoplakia in HIV-infected adults in North Carolina. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 99: 39-47. PMID 15599347 DOI: 10.1016/J.Tripleo.2004.06.081  0.577
2004 Chattopadhyay A, Gray LR, Patton LL, Caplan DJ, Slade GD, Tien HC, Shugars DC. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons. Infection and Immunity. 72: 1956-63. PMID 15039315 DOI: 10.1128/Iai.72.4.1956-1963.2004  0.531
2003 Freel SA, Fiscus SA, Pilcher CD, Menezes P, Giner J, Patrick E, Lennox JL, Hicks CB, Eron JJ, Shugars DC. Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection. Aids (London, England). 17: 2025-33. PMID 14502005 DOI: 10.1097/00002030-200309260-00003  0.72
2002 Patton LL, Santos VA, McKaig RG, Shugars DC, Strauss RP. Education in HIV risk screening, counseling, testing, and referral: survey of U.S. dental schools. Journal of Dental Education. 66: 1169-77. PMID 12449212 DOI: 10.1002/J.0022-0337.2002.66.10.Tb03590.X  0.583
2002 Gray LR, Alexander AL, Shugars DC. Construction, non-denaturing affinity purification, and characterization of baculovirally expressed human secretory leukocyte protease inhibitor. Protein Expression and Purification. 26: 179-86. PMID 12356486 DOI: 10.1016/S1046-5928(02)00529-6  0.305
2002 Shugars DC, Sweet SP, Malamud D, Kazmi SH, Page-Shafer K, Challacombe SJ. Saliva and inhibition of HIV-1 infection: molecular mechanisms. Oral Diseases. 8: 169-75. PMID 12164652 DOI: 10.1034/J.1601-0825.8.S2.7.X  0.637
2001 Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, Giner J, Dean B, Robertson K, Hart CE, Lennox JL, Eron JJ, Hicks CB. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. Aids (London, England). 15: 837-45. PMID 11399956 DOI: 10.1097/00002030-200105040-00004  0.639
2001 Shugars DC, Patton LL, Freel SA, Gray LR, Vollmer RT, Eron JJ, Fiscus SA. Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva. Journal of Dental Research. 80: 414-20. PMID 11332524 DOI: 10.1177/00220345010800020301  0.737
2001 Freel SA, Williams JM, Nelson JA, Patton LL, Fiscus SA, Swanstrom R, Shugars DC. Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses. Journal of Virology. 75: 4936-40. PMID 11312368 DOI: 10.1128/Jvi.75.10.4936-4940.2001  0.717
2000 Cohen MS, Shugars DC, Fiscus SA. Limits on oral transmission of HIV-1 Lancet. 356: 272. PMID 11071180 DOI: 10.1016/S0140-6736(00)02500-9  0.672
2000 Shugars DC, Slade GD, Patton LL, Fiscus SA. Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 89: 432-40. PMID 10760726 DOI: 10.1016/S1079-2104(00)70124-7  0.669
2000 Shepard RN, Schock J, Robertson K, Shugars DC, Dyer J, Vernazza P, Hall C, Cohen MS, Fiscus SA. Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. Journal of Clinical Microbiology. 38: 1414-8. PMID 10747117 DOI: 10.1128/Jcm.38.4.1414-1418.2000  0.574
1999 Patton LL, Shugars DC. Immunologic and viral markers of HIV-1 disease progression: implications for dentistry. Journal of the American Dental Association (1939). 130: 1313-22. PMID 10492538 DOI: 10.14219/Jada.Archive.1999.0401  0.645
1999 Shugars DC, Alexander AL, Fu K, Freel SA. Endogenous salivary inhibitors of human immunodeficiency virus. Archives of Oral Biology. 44: 445-53. PMID 10401522 DOI: 10.1016/S0003-9969(99)00003-5  0.724
1999 Shugars DC. Endogenous mucosal antiviral factors of the oral cavity Journal of Infectious Diseases. 179. PMID 10099113 DOI: 10.1086/314799  0.681
1998 Shugars DC, Wahl SM. The Role of the Oral Environment in HIV-1 Transmission Journal of the American Dental Association. 129: 851-858. PMID 9685760 DOI: 10.14219/Jada.Archive.1998.0349  0.672
1998 Weinberg JB, Shugars DC, Sherman PA, Sauls DL, Fyfe JA. Cobalamin inhibition of HIV-1 integrase and integration of HIV-1 DNA into cellular DNA Biochemical and Biophysical Research Communications. 246: 393-397. PMID 9610370 DOI: 10.1006/Bbrc.1998.8629  0.606
1998 Rimsky LT, Shugars DC, Matthews TJ. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. Journal of Virology. 72: 986-93. PMID 9444991 DOI: 10.1128/Jvi.72.2.986-993.1998  0.469
1997 Shugars DC, Sauls DL, Weinberg JB. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I Oral Diseases. 3. PMID 9456661 DOI: 10.1111/J.1601-0825.1997.Tb00379.X  0.682
1997 Wahl S, McNeely T, Janoff E, Shugars D, Worley P, Tucker C, Orenstein J. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV‐1 Oral Diseases. 3. PMID 9456660 DOI: 10.1111/J.1601-0825.1997.Tb00377.X  0.633
1997 McNeely TB, Shugars DC, Rosendahl M, Tucker C, Eisenberg SP, Wahl SM. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription Blood. 90: 1141-1149. PMID 9242546 DOI: 10.1182/Blood.V90.3.1141  0.551
1996 Shugars DC, Wild CT, Greenwell TK, Matthews TJ. Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. Journal of Virology. 70: 2982-91. PMID 8627774  0.362
1995 Wild C, Greenwell T, Shugars D, Rimsky-Clarke L, Matthews T. The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. Aids Research and Human Retroviruses. 11: 323-325. PMID 7786578 DOI: 10.1089/Aid.1995.11.323  0.488
1995 Weinberg JB, Sauls DL, Misukonis MA, Shugars DC. Inhibition of productive human immunodeficiency virus-1 infection by cobalamins Blood. 86: 1281-1287. PMID 7632933 DOI: 10.1182/Blood.V86.4.1281.Bloodjournal8641281  0.621
1994 Wild CT, Shugars DC, Greenwell TK, McDanal CB, Matthews TJ. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection Proceedings of the National Academy of Sciences of the United States of America. 91: 9770-9774. PMID 7937889 DOI: 10.1073/pnas.91.21.9770  0.507
1993 Anderson S, Shugars DC, Swanstrom R, Garcia JV. Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells Journal of Virology. 67: 4923-4931. PMID 8331733 DOI: 10.1128/Jvi.67.8.4923-4931.1993  0.372
1993 Shugars DC, Smith MS, Glueck DH, Nantermet PV, Seillier-Moiseiwitsch F, Swanstrom R. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo Journal of Virology. 67: 4639-4650. PMID 8043040 DOI: 10.1128/Jvi.67.8.4639-4650.1993  0.485
Show low-probability matches.